SERCA2a: a prime target for modulation of cardiac contractility during heart failure

키워드

참고문헌 (46)

1. Braz, J. C., "PKC-alpha regulates cardiac contractility and propensity toward heart failure.", Nat. Med, 10, pp.248~254 (2004)
2. Byrne, M. J., "Recirculating cardiac delivery of AAV2", 1SERCA2a improves myocardial function in an experimental model of heart failure in large animals, 2008, pp.15, 1550~1557
3. Carr, A. N., "Type 1 phosphatase, a negative regulator of cardiac function", Mol. Cell. Biol, 22, pp.4124~4135 (2002)
4. del Monte, F., "Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure", Circ. Res, 88, pp.E66~E67 (2001)
5. del Monte, F., "Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a", Circulation, 100, pp.2308~2311 (1999)
6. El-Armouche, A., "Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes", FASEB J, 17, pp.437~439 (2003)
7. Endo, S., "Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor", Biochemistry, 35, pp.5220~5228 (1996)
8. Gupta, R. C., "Evidence for presence and hormonal regulation of protein phosphatase inhibitor-1 in ventricular cardiomyocyte", Am. J. Physiol, 270, pp.H1159~H1164 (1996)
9. Gwathmey, J. K., "Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure", Circ. Res, 61, pp.70~76 (1987)
10. Haghighi, K., "Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human", J. Clin. Invest, 111, pp.869~876 (2003)
11. Hajjar, R. J., "Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase", Circ. Res, 81, pp.145~153 (1997)
12. Hajjar, R. J., "Modulation of ventricular function through gene transfer in vivo", Proc. Natl. Acad. Sci. U.S.A, 95, pp.5251~5256 (1998)
13. Hambleton, M., "Pharmacological-and gene therapy-based inhibition of protein kinase Calpha", beta enhances cardiac contractility and attenuates heart failure, 2006, pp.114, 574~582
14. Hasenfuss, G., "Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)- ATPase in failing and nonfailing human myocardium", Circ. Res, 75, pp.434~442 (1994)
15. Houser, S. R., "Abnormalities of calcium cycling in the hypertrophied and failing heart", J. Mol. Cell Cardiol, 32, pp.1595~1607 (2000)
16. Jaski, B. E., "Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1", 2 clinical trial, 2009, pp.15, 171~181
17. Jessup, M., "Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure", Circulation, 124, pp.304~313 (2011)
18. Ji, Y., "Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function", J. Biol. Chem, 275, pp.38073~38080 (2000)
19. Kadambi, V. J., "Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice", J. Clin. Invest, 97, pp.533~539 (1996)
20. Kawase, Y., "Reversal of cardiac dysfunction after long- term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure", J. Am. Coll. Cardiol, 51, pp.1112~1119 (2008)
21. Kho, C., "SUMO1-dependent modulation of SERCA2a in heart failure", Nature, 477, pp.601~605 (2011)
22. Ladage, D., "Inhibition of PKCalpha", beta with ruboxistaurin antagonizes heart failure in pigs after myocardial infarction injury, 2011, pp.109, 1396~1400
23. Lehnart, S. E., "Novel targets for treating heart and muscle disease: stabilizing ryanodine receptors and preventing intracellular calcium leak", Curr. Opin. Pharmacol, 7, pp.225~232 (2007)
24. Lehnart, S. E., "Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart", Heart. Fail. Rev, 14, pp.213~224 (2009)
25. Limas, C. J., "Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy", Cardiovasc Res, 21, pp.601~605 (1987)
26. Liu, Q., "Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach", Circ. Res, 105, pp.194~200 (2009)
27. Lopez, A. D., "Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data", Lancet, 367, pp.1747~1757 (2006)
28. Luo, W., "Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation", Circ. Res, 75, pp.401~409 (1994)
29. Luo, W., "Phospholamban gene dosage effects in the mammalian heart", Circ. Res, 78, pp.839~847 (1996)
30. MacDougall, L. K., "Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban", Eur. J. Biochem, 196, pp.725~734 (1991)
31. Mathers, C. D., "Global and regional causes of death", Br. Med. Bull, 92, pp.7~32 (2009)
32. Mathers, C. D., "Projections of global mortality and burden of disease from 2002 to 2030", PLoS Med, 3, pp.e442~ (2006)
33. Mercadier, J. J., "Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure", J. Clin. Invest, 85, pp.305~309 (1990)
34. Movsesian, M. A., "Identification and characterization of proteins in sarcoplasmic reticulum from normal and failing human left ventricles", J. Mol. Cell Cardiol, 22, pp.1477~1485 (1990)
35. Neumann, J., "Increased expression of cardiac phosphatases in patients with end-stage heart failure", J. Mol. Cell Cardiol, 29, pp.265~272 (1997)
36. Neumann, J., "Evidence for isoproterenol- induced phosphorylation of phosphatase inhibitor- 1 in the intact heart", Circ. Res, 69, pp.1450~1457 (1991)
37. Nicolaou, P., "Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia", reperfusion injury, 2009, pp.104, 1012~1020
38. Oh, J. G., "Decoy peptides targeted to protein phosphatase 1 inhibit dephosphorylation of phospholamban in cardiomyocytes", J. Mol. Cell Cardiol, 56, pp.63~71 (2013)
39. Pathak, A., "Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1", Circ. Res, 96, pp.756~766 (2005)
40. Periasamy, M., "Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene", J. Biol. Chem, 274, pp.2556~2562 (1999)
41. Prunier, F., "Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion", Circulation, 118, pp.614~624 (2008)
42. Rodriguez, P., "Phosphorylation of human inhibitor- 1 at Ser67 and", or Thr75 attenuates stimulatory effects of protein kinase A signaling in cardiac myocytes, 2007, pp.293, H762~H769
43. Rodriguez, P., "Identification of a novel phosphorylation site in protein phosphatase inhibitor-1 as a negative regulator of cardiac function", J. Biol. Chem, 281, pp.38599~38608 (2006)
44. Schultz Jel, J., "Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity", Am. J. Physiol. Heart. Circ. Physiol, 286, pp.H1146~H1153 (2004)
45. Steenaart, N. A., "The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme", Arch. Biochem. Biophys, 293, pp.17~24 (1992)
46. Yano, M., "Abnormal ryanodine receptor function in heart failure", Pharmacol. Ther, 107, pp.377~391 (2005)

관련 논문AI추천